The research assignment requirement can be found in the description section.

User Generated

ozp193564

Science

Biology human anatomy and pysiology

Description

Out of the four (4) research files uploaded, select at least two (2) topics and make significant contributions. This can include questions, reflections, offering another perspective, and additional information.

Note: For each of the topics selected, 100 -150 words and with at least one (1) reference each.

Unformatted Attachment Preview

What is Rabies? July 5, 2018 Rabies Since the 1990’s rabies has been at the source of “zombies” throughout entertainment. That if this goes untreated you will essentially turn into a zombie. This is not true at all. If rabies goes untreated you will die, there are no chances for survival without the vaccination and even then, it could still cause death if you wait to long to receive treatment. In society there have been several movies that portray what rabies is and of course shows that portray the zombie version. Rabies is a serious virus that will kill you if it goes untreated and it takes a toll on your mental and physical health. How is this virus spread? What is Rabies? Rabies is spread from animals who have the virus and they bite you and this gets into your blood stream. Rabies is the United States is statistically lower than those around the world with over 99% of deaths taking place in Africa and Asia (Lee, 2018). Rabies not only affects wild animals, but it can also affect domesticated animals as well which also contracts back to humans if they are bitten by an affected animal. Wilderness animals just alone in the United States that have been known for carrying the disease are coyotes, raccoons, bats, skunks and foxes. The signs and symptoms of rabies include but are not limited to: signs of the flu, weakness, fever or headache and they typically last for a couple of days. Other signs include a rash or irritation at the site of the bite, confusion, dementia, and as the disease progresses people will also be presented with insomnia and hallucinations (Johnson, 2015). There is an acute period of the disease for it to incubate and that is anywhere from day one to day ten. Once these signs appear the survival rate is almost nonexistent (Johnson, 2015). Effects of the disease on healthy body function The effects of this disease on a normal functioning body are once a person is bitten by an infected animal the disease travels within the blood stream through the nerves to the brain. Once the disease has reached the brain, the swelling of the brain will immense and the disease will multiply. This will then travel from the brain through the blood stream to the salvia glands (Johnson, 2015). This process can take anywhere from a week to several weeks for this to be out of the incubation period and for signs to start showing. An affected person will usually die if untreated after the symptoms have been present for a week (De Cruz Matos, 2017). Prevention The preventative steps for this are to not mess with any wildlife animals that seem disturbed or nocturnal animals that come out during the day, leave the animal alone, and if you suspect your own animals has been bitten take them to a veterinarian so they can properly asses and diagnose your pet before the disease spreads. If you have been bitten by an animal that you suspect might have rabies go to your doctor immediately and inform them, so they can diagnose you. Diagnostics in humans are different than those in animals as animals must be euthanized to be tested and samples of brain tissue are used for the tests. In humans, several tests are run to rule out rabies these include but are not limited to spinal fluid tap, skin biopsies and saliva testing (Johnson, 2015). Symptoms Once someone has been diagnosed with the rabies disease This is presented in the form of a shot. “Several studies have investigated the efficacy of G protein (purified from infected cells) for rabies protection, since RABV G protein is the major determinant of viral pathogenicity and is also the major protective antigen responsible for inducing protective immunity against rabies (Shimao, Z., & Caiping, G., 2016). If the disease is caught in enough time before it spreads than the rabies vaccinations will increase the chance of survival. Possible Treatments Future testing for a cure suggests that nucleic acid will be able to mimic the live virus and provide a higher survival rate. “Other advantages of nucleic acidbased vaccines include stability, low production costs, ease of development and purification, and scaling up of production being much simpler compared to that of purified protein vaccines or viral vaccines” (Shimao, & Caiping, 2016). There is a study that is currently being tested and that involves taking antibiotics along with getting the rabies vaccination versus just the rabies vaccination (Rouphael, 2018). “RABV undergoes relatively frequent cross-species transmission [8, 11, 13, 18], which provides an opportunity to determine whether host jumping impacts rates of evolutionary change” (Troupin, 2016). Conclusion In conclusion, we know that rabies is transmitted through wild animals that contain the disease and humans can contract the disease by getting bit by the rabid animals. We learned that if we see an animal displaying aggressive or abnormal behaviors we leave it alone and contact our local animal control officer or DNR. If our own animal is bitten by an animal, we need to take them in and get them tested so they don’t get the disease. We also learned that there is still no definite cure for rabies as the survival rate is not that promising. There are several options and studies that are suggesting other ways and methods for testing and mimicking the live virus for a higher survival rate. References: Da Cruz Matos, J., Rodrigues Mafra, C., De Miranda Andretta, A. G., & Rayanne Alves, L. (2017). Human Anti-Rabies Accompaniment and Consequent Adherence to PostExposure Prophylaxis. Journal of Nursing UFPE / Revista De Enfermagem UPFE, 314511457. Doi: 10.5205/reuol.1026 Anh, D. D., Duong, ine.com/health/rabi T. N., Lee, M., & es Grace, D. (2018). Geographical and Temporal Patterns of Rabies Post Exposure Prophylaxis (PEP) incididence in humans in the Mekong River Delta and Southeast Central Coast regions in Vietnam from 2005 to 2015. Plos ONE, 13(4), 1-12 doi:10.1371/journal Biology of Inactivated Rabies Vaccine in Healthy Adults with or Without Use of Broad Spectrum Antibiotics. Retrieved July 5, 2018 from: https://clinicaltrials. gov/ct2/show/NCT 03557008?cond=R abies+Human&ran k=1 Senthilkimaran, S., Johnson, S. (2015, Oct 19). 1103sup201717d Rabies. Retrieved H. Thiem, V. D., 14). Systems .pone.0194943 3-91568-1RV. Lee, H. s., Nguyen-Viet, Rouphael, N. (2018, June July 5, 2018 from: https://www.healthl Balamurugan, N., Kathikeyan, N., & Thirumalaikolundu subramanian, P., (2018). Rabies Bouchier, C., Treatment: Are We Sabeta, C., & Anywhere Close to Duchene, S. Cure? Indian (2016). Large-Scale Journal of Critical Phylogenomic Care Medicine, Analysis Revelas 22(3), 199-200 doi: the Complex 10.4103/ijccm.IJC Evolutionary CM 8_18 History of Rabies Shimao, Z., & Caiping, G. (2016). Rabies Control and Treatment: From Prophylaxis to Strategies with Curative Potential. Viruses (19994915), 8(11), 1-23. doi:10.3390/v8110 279 Troupin, C., Dacheux, L., Bourhy, H., Tanguy, M., Virus in Multiple Carnivore Hosts. Plos Pathogens, 12(12), 1-20. doi: 10.1371/journal.pp at. 1006041 Parkinson’s Disease Biology 301 clumps of the protein alpha-synuclein. (“Parkinson’s Disease,” 2017) Symptoms can include but are not limited to: What is Parkinson’s disease? Parkinson’s disease (PD) is a neurodegenerative disorder that affects predominantly dopamine-producing (“dopaminergic”) neurons in a specific area of the brain called substantia nigra. Parkinson's disease occurs when nerve cells, or neurons, in an area of the brain that controls movement become impaired and/or die. Normally, these neurons produce an important brain chemical known as dopamine. When the neurons die or become impaired, they produce less dopamine, which causes the movement problems of Parkinson's. (“Parkinson’s Disease,” 2017) The disease is a chronic and progressive disorder of the central nervous system that affects movement, often including tremors. Signs and Symptoms Symptoms of Parkinson’s disease vary with every patient and can progress over time. Patients with Parkinson's also lose the nerve endings that produce norepinephrine, the main chemical messenger of the sympathetic nervous system, which controls many automatic functions of the body, such as heart rate and blood pressure. The loss of norepinephrine might help explain some of the non-movement features of Parkinson's, such as fatigue, irregular blood pressure, decreased movement of food through the digestive tract, and sudden drop in blood pressure when a person stands up from a sitting or lying-down position. Many brain cells of people with Parkinson's contain Lewy bodies, unusual • • • • • • • • • Tremors Slowed movement (bradykinesia) Rigid muscles Impaired posture and balance (“Parkinson’s Disease,” 2017) Changes in speech Depression (other emotional changes) Urinary problems Skin problems Sleep disruptions (“Parkinson’s disease,” 2018) Effects on a healthy body During the initial stage patients may experience mild symptoms that generally do not interfere with daily activities. In stage two the symptoms begin to worsen with tremors, rigidity, and other movement symptoms possibly affecting both sides of the body or just one. Stage three is considered mid-stage, loss of balance and slowness of movements are the hallmark and falls become more common. The patient could still be independent, but symptoms can significantly impair daily activities such as getting dressed and eating. In stage four symptoms are severe and limiting but still can be possible to stand without assistance. Stage five which is also the most advanced and debilitating stage can cause stiffness in the legs and make it impossible to stand or walk, requiring the patient to have around the clock care. (Downard, 2017) Risk factors Parkinson’s disease is an extremely diverse disorder. Risk factors for Parkinson’s disease include age, sex, heredity, and exposure to toxins. Young adults rarely experience Parkinson's disease. It ordinarily begins in middle or late life, and the risk increases with age. People usually develop the disease around age 60 or older. Increasing age is a risk factor for PD, as the incidence of PD increases with age. PD affects 1% of the population over the age of 60, and this increases to 5% of the population over the age of 85. Only about 5% of all people with PD are diagnosed before the age of 60, which is considered early onset PD. (Downward, 2017) Having a close relative with Parkinson's disease increases the chances that you'll develop the disease. However, your risks are still small unless you have many relatives in your family with Parkinson's disease. (“Parkinson’s disease,” 2018) Preventative Steps and Treatment The cause of Parkinson's is unknown, proven ways to prevent the disease also remain a mystery. Some research has shown that regular aerobic exercise might reduce the risk of Parkinson's disease. Some other research has shown that people who drink caffeine, which is found in coffee, tea and cola, get Parkinson's disease less often than those who don't drink it. However, it is still not known whether caffeine actually protects against getting Parkinson's, or is related in some other way. Currently there is not enough evidence to suggest drinking caffeinated beverages to protect against Parkinson's. Green tea is also related to a reduced risk of developing Parkinson's disease. (Parkinson’s disease, 2018) Although there is no cure for Parkinson's disease, medicines, surgical treatment, and other therapies can often relieve some symptoms. The main therapy for Parkinson's is levodopa, also called L-dopa. Nerve cells use levodopa to make dopamine to replenish the brain's dwindling supply. Usually, people take levodopa along with another medication called carbidopa. Carbidopa prevents or reduces some of the side effects of levodopa therapy—such as nausea, vomiting, low blood pressure, and restlessness—and reduces the amount of levodopa needed to improve symptoms. (“Parkinson’s Disease,” 2017) Current and future research areas of prevention and treatment Although the treatment plan for every patient varies there is no cure for Parkinson’s disease. The Parkinson's Disease-Biomarkers Programs (PDBP), a major NINDS initiative, aims to discover how to identify those at risk for Parkinson's and to track its progression. Identifying biomarkers—signs that may indicate risk for and improve diagnosis of a disease— will speed development of new Parkinson's treatments. The NINDS Morris K. Udall Centers of Excellence for Parkinson's disease Research program is a central component of NINDS Parkinson's research to find the causes of Parkinson's and better diagnose and treat people with the disease. The NINDS currently funds 10 Udall Centers across the country, where researchers are examining the disease's mechanisms, the genetic contributions to Parkinson's, and potential therapeutic targets and treatment strategies. Current Parkinson's studies include ones on genetics, biomarkers, experimental therapies and other treatment options, diagnostic imaging, brain control and movement disorders, DBS, and exercise. (“What Research is Being Done?” 2014) Conclusion This pamphlet aimed to educate on Parkinson’s disease signs and symptoms, prevention, risk factors, and treatments. Unfortunately, there is no clear answer to give patients on how they got the disease and how to cure it, there is a pressing need to immediately identify possible symptoms the patients are going through. Symptom identification and rapid response is currently the only means of helping the patients prolong their life with minimal symptom affects. Parkinson’s Disease Biology 301 clumps of the protein alpha-synuclein. (“Parkinson’s Disease,” 2017) Symptoms can include but are not limited to: What is Parkinson’s disease? Parkinson’s disease (PD) is a neurodegenerative disorder that affects predominantly dopamine-producing (“dopaminergic”) neurons in a specific area of the brain called substantia nigra. Parkinson's disease occurs when nerve cells, or neurons, in an area of the brain that controls movement become impaired and/or die. Normally, these neurons produce an important brain chemical known as dopamine. When the neurons die or become impaired, they produce less dopamine, which causes the movement problems of Parkinson's. (“Parkinson’s Disease,” 2017) The disease is a chronic and progressive disorder of the central nervous system that affects movement, often including tremors. Signs and Symptoms Symptoms of Parkinson’s disease vary with every patient and can progress over time. Patients with Parkinson's also lose the nerve endings that produce norepinephrine, the main chemical messenger of the sympathetic nervous system, which controls many automatic functions of the body, such as heart rate and blood pressure. The loss of norepinephrine might help explain some of the non-movement features of Parkinson's, such as fatigue, irregular blood pressure, decreased movement of food through the digestive tract, and sudden drop in blood pressure when a person stands up from a sitting or lying-down position. Many brain cells of people with Parkinson's contain Lewy bodies, unusual • • • • • • • • • Tremors Slowed movement (bradykinesia) Rigid muscles Impaired posture and balance (“Parkinson’s Disease,” 2017) Changes in speech Depression (other emotional changes) Urinary problems Skin problems Sleep disruptions (“Parkinson’s disease,” 2018) Effects on a healthy body During the initial stage patients may experience mild symptoms that generally do not interfere with daily activities. In stage two the symptoms begin to worsen with tremors, rigidity, and other movement symptoms possibly affecting both sides of the body or just one. Stage three is considered mid-stage, loss of balance and slowness of movements are the hallmark and falls become more common. The patient could still be independent, but symptoms can significantly impair daily activities such as getting dressed and eating. In stage four symptoms are severe and limiting but still can be possible to stand without assistance. Stage five which is also the most advanced and debilitating stage can cause stiffness in the legs and make it impossible to stand or walk, requiring the patient to have around the clock care. (Downard, 2017) Risk factors Parkinson’s disease is an extremely diverse disorder. Risk factors for Parkinson’s disease include age, sex, heredity, and exposure to toxins. Young adults rarely experience Parkinson's disease. It ordinarily begins in middle or late life, and the risk increases with age. People usually develop the disease around age 60 or older. Increasing age is a risk factor for PD, as the incidence of PD increases with age. PD affects 1% of the population over the age of 60, and this increases to 5% of the population over the age of 85. Only about 5% of all people with PD are diagnosed before the age of 60, which is considered early onset PD. (Downward, 2017) Having a close relative with Parkinson's disease increases the chances that you'll develop the disease. However, your risks are still small unless you have many relatives in your family with Parkinson's disease. (“Parkinson’s disease,” 2018) Preventative Steps and Treatment The cause of Parkinson's is unknown, proven ways to prevent the disease also remain a mystery. Some research has shown that regular aerobic exercise might reduce the risk of Parkinson's disease. Some other research has shown that people who drink caffeine, which is found in coffee, tea and cola, get Parkinson's disease less often than those who don't drink it. However, it is still not known whether caffeine actually protects against getting Parkinson's, or is related in some other way. Currently there is not enough evidence to suggest drinking caffeinated beverages to protect against Parkinson's. Green tea is also related to a reduced risk of developing Parkinson's disease. (Parkinson’s disease, 2018) Although there is no cure for Parkinson's disease, medicines, surgical treatment, and other therapies can often relieve some symptoms. The main therapy for Parkinson's is levodopa, also called L-dopa. Nerve cells use levodopa to make dopamine to replenish the brain's dwindling supply. Usually, people take levodopa along with another medication called carbidopa. Carbidopa prevents or reduces some of the side effects of levodopa therapy—such as nausea, vomiting, low blood pressure, and restlessness—and reduces the amount of levodopa needed to improve symptoms. (“Parkinson’s Disease,” 2017) Current and future research areas of prevention and treatment Although the treatment plan for every patient varies there is no cure for Parkinson’s disease. The Parkinson's Disease-Biomarkers Programs (PDBP), a major NINDS initiative, aims to discover how to identify those at risk for Parkinson's and to track its progression. Identifying biomarkers—signs that may indicate risk for and improve diagnosis of a disease— will speed development of new Parkinson's treatments. The NINDS Morris K. Udall Centers of Excellence for Parkinson's disease Research program is a central component of NINDS Parkinson's research to find the causes of Parkinson's and better diagnose and treat people with the disease. The NINDS currently funds 10 Udall Centers across the country, where researchers are examining the disease's mechanisms, the genetic contributions to Parkinson's, and potential therapeutic targets and treatment strategies. Current Parkinson's studies include ones on genetics, biomarkers, experimental therapies and other treatment options, diagnostic imaging, brain control and movement disorders, DBS, and exercise. (“What Research is Being Done?” 2014) Conclusion This pamphlet aimed to educate on Parkinson’s disease signs and symptoms, prevention, risk factors, and treatments. Unfortunately, there is no clear answer to give patients on how they got the disease and how to cure it, there is a pressing need to immediately identify possible symptoms the patients are going through. Symptom identification and rapid response is currently the only means of helping the patients prolong their life with minimal symptom affects. SHINGLES 1 Target and Infections Shingles Introduction Shingles are said to have existed since the middle ages. Shingles, referred to as herpes zoster, and is known to be a disease primarily described by painful skin rash together with blisters localized in the same area. Based on this preamble, the discussion will focus on signs and symptoms, target and infections, causes and transmission, diagnoses, risk factors, prognosis, effects, treatment, and prevention. Regardless of the complexity of the disease, Shingles is a solvable disease with simple measures substantiating a healthy living. What is Shingles? While it appears to be a common phenomenon family to chickenpox, the definition of shingles is an extra puzzle that similarly calls for research. Shingles can best be described as a disease that is mainly characterized by a painful and blistering skin rash which affects only one side of the entire body (Naveen et al., 2014). The most affected parts include the torso or the face. The condition is commonly referred to as the herpes zoster, and researchers would casually dub the disease as Zona or Zoster (Wehrhahn & Dwyer, 2012). As said before, after episodes of chickenpox, the virus can reactivate with time thereby leading to shingles. Over 25% of all adults around the world would have shingles in their lifetime with a good percentage sharing a history of chickenpox (Bader, 2013). Another target group includes people with medical conditions such as cancer and HIV (Schmidt et al., 2017). Lastly, people with emotional and psychological stressors have high chances of developing shingles. Signs and Symptoms The primary symptoms include malaise, fever, and headache. With time, the infected person can feel some sensations of itching, paresthesia, hyperesthesia, burning pain and even tingling (Wehrhahn & Dwyer, 2012). The sensations can be interspersed with instant stabs which are accompanied by agonizing pain. However, shingles are often painless in children with the tendency of contracting shingles increases with age. The rashes look similar to hives with the skin changing to a dermatome, which results in a stripe (Naveen et al., 2014). Causes and Transmission The primary cause of shingles is typically as a result of reactivation or revival of the varicella-zoster virus. The cause of reactivation is always unclear apart from tracking the history of chickenpox (Wehrhahn & Dwyer, 2012). In children, varicella is normally selflimiting and mild. The transmission, at this stage, is airborne while involving persons with vesicles carrying the zoster or varicella. Test, Diagnostic and Therapeutic Tools Some of the tests under consideration include the polymerase chain reaction, often referred to as PCR, which is performed to determine possible cases influenced by zoster sine herpete (Bader, 2013). Serologic methods can as well be applied with any presence of the zoster indicating transient IgM response. Any positive IgM ELISA can be a potential indicator of the VZV infection, reactivation and reinfection. Effects of the Disease on the Functions of the Body The first part of the body to be affected by shingles includes the eye. Shingles would tamper with the facial nerve where a branch of the same nerve involves the eye. Eye infections and the injurious impact demand the most immediate medical attention, in which the absence of it would result into vision SHINGLES damage and loss (Schmidt et al., 2017). The second impact of shingles involves the post-herpetic neuralgia, which is commonly referred to as PHN. Research indicates that almost 20% of the cases involve people who develop PHN due to shingles infections (Wehrhahn & Dwyer, 2012). Risk Factors The first group of factors includes the lifestyle and socio-demographic factors (Schmidt et al., 2017). Based on this group factors, age, gender, and genetic susceptibility are the evident elements. The second group of factors includes the somatic diseases as well as treatments. An additional group of risk factors includes the mood disorders and psychological stress. The last factor is occult cancer which increases the risk of zoster through immunosuppression via chemotherapy and radiation. Expected Outcomes/prognosis Some of the complications have been discussed before. The common HZ complication is PHN, which is normally characterized by neuropathic pain. Age is a potential predictor of PNH because the complication worsens with age PNH leads to nerve pain and damages the peripheral nerve as a result of the reactivated varicella 2 zoster virus (Sampathkumar, Drage & Martin, 2009). The two are common in most of the immunocompromised individuals. Treatment With time, shingles would heal by themselves even without any form of intervention. However, research has led to the development of a variety of drugs that can treat the complications. The recommended medications are to be taken from the point the rash appears. The purpose of engaging the treatment is to make sure that the healing process is hastened while reducing the severity as well as the duration of the chronic pain. The premiered form of treating shingles is by use of the antiviral therapy. Some of the agents used include valacyclovir (Valtrex), acyclovir (Zovirax) and famciclovir (Novartis) have the potential of reducing the duration and severity of HZ infection. Nevertheless, the topical agents are believed to be ineffective in treating herpes zoster. Acyclovir is of standard gold treatment with few cases of VZV resistance, which has never been an issue. Valacyclovir is an oral prodrug attached to acyclovir, and it is useful when applied within the parent compound. Besides, famciclovir is a penciclovir prodrug and exhibits bioavailability when compared to active metabolite and acyclovir. In addition, the drugs may not be convenient for acute pain; hence, the tricyclic antidepressants, narcotic analgesics, and the nonsteroidal antiinflammatory drugs are often more recommendable. Besides, the acetaminophen can be applied together with the antiviral therapy to meet the desired efficacy. For the chronic pain, the antiviral drugs are effective in dimming the PNH pain (Watkins, 2010). In addition, anesthetics, antidepressants, narcotics and anti-epileptic agents can provide relief. On the other hand, the tricyclic antidepressants can be used in managing the neuropathic pain, which can be preceded by amitriptyline. Regardless of the type of drug described for any state of herpes zoster, the essential element observed during the treatment is the PNH. Regulating acute HZ pain may improve the health-related value of an individual’s life and the functional position as well (Sampathkumar, Drage & Martin, 2009). Effective treatment with dexamethasone as well as ganglion blockade with dexamethasone and bupivacaine shows positive results in preventing PHN. Systemic corticosteroids are seemingly ineffective but can as well reduce the entire duration of the acute neuritis. Sometimes, management of PNH demands multifaceted therapeutic approach because of the severity of the symptoms as well as the duration of the disease. SHINGLES A revisit of the pharmacological treatment also leads to a variety of options. Some of the treatments that are still relevant include the anticonvulsant drugs, which are normally applied in the neuropathic pain. Under the same category, pregabalin and gabapentin are drugs that perform the same way as gammaaminobutyric acid. Nonetheless, the two drugs have less capability of acting on GABA receptor. Pregabalin is safer and effective when acting on PHN (Watkins, 2010). Another class of the pharmacological treatment includes the opioids, which is effective for moderate or severe pain. In addition, capsaicin is always a pepper-derived alkaloid, which usually acts on the neuropathic pain. Lidocaine is usually considered as the first line drug used in treating PHN. The drug acts by blocking the sodium channels while limiting the abnormal ectopic discharges. Lastly, doctors would recommend spinal cord stimulation, which usually treats the chronic neuropathic pain. Prevention The first preventive measure is by use of vaccines, which is known to bolster the immune system to a stable level that can counter the herpes zoster infection (Bharucha, Ming & Breuer, 2017). The recently voted vaccine by FDA is the GlaxoSmithKline new vaccine, which is 3 known as shingrix. Zostavax is also a potential vaccine that can perfectly substitute shingrix. Additional Information First, medical research has invested in the development of drugs believed to be strong enough in fighting diseases, as well as treating or preventing the complications (Cohen et al., 2013). The other goal entails understanding the trend of diseases while predicting the future behaviors of the same diseases. Conclusion In summation, this pamphlet aimed at educating on shingles. The disease proves to be a complication that draws a close relationship with chickenpox. Other areas of concern include the effects, prognosis, treatment, and prevention. The notorious virus behind herpes zoster is referred to as varicella-zoster that resembles the infection that leads to chickenpox in the prior episodes. The prime cause of shingles is the reactivation process of the VZV, which comes after many years since the last episode of chickenpox. The discussion has extensively explored the risk factors that can lead to HZ infection. Some of the factors include sociodemographic factors, stress, and people under medications such as cancer treatment and HIV/AIDS. The impressive side includes the tests, diagnostic and therapeutic tools. Laboratory tests are recommendable for the purposes of detecting the infection. Diagnosis consists of the PCR tests that can efficiently provide a lead to the detection of PHN. Shingles have scaring outcomes such as encephalitis, eye problems, swelling and Ramsay Hunt syndrome. Treatment can be accomplished via drug usage such as acyclovir among others. Preventive measures include making use of vaccines and managing body contacts. While being infected with Shingles, it is recommendable to observe the hygienic conditions. Researchers are also focusing on possibilities of transmission of the virus through saliva.
Purchase answer to see full attachment
User generated content is uploaded by users for the purposes of learning and should be used following Studypool's honor code & terms of service.

Explanation & Answer

Attached.

Surname1

Name:
Tutor:
Course:
Date:
Parkinson’s disease
Parkinson’s is a disorder which affects predominantly dopamine which makes it produce
fluid in a particular location of the brain. The disease happens when the nerve cells which
controls movements in the brain become impaired.
The signs and symptoms of Parkinson’s disease vary depending on the patient. The
patient experience the loss of nerve ending which produces norepinephrine. The symptoms
include tremo...


Anonymous
Very useful material for studying!

Studypool
4.7
Trustpilot
4.5
Sitejabber
4.4

Related Tags